Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients

References

• Langford HG, Blaufox MD. Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection Follow-up Program. Arch Intern Med. 1987;147: 645–650.
   PubMed Web of Science ®Google Scholar
• Franse LV. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program. J Hypertens. 2000;18:1149–1154.
   PubMed Web of Science ®Google Scholar
• The Hypertension Detection and Follow-up Program Cooperative Research Group. Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. Prev Med. 1985;14:312–335.
   PubMed Web of Science ®Google Scholar
• Staessen J. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med. 1991;90:50–54.
   Web of Science ®Google Scholar
• Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension. 1999;34:144–150.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension. 2000;36:1072–1078.
   PubMed Web of Science ®Google Scholar
• Wang JG, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L, for the Systolic Hypertension in China (Syst-China) Trial Collaborative Group. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension. 2001;37: 1069–1074.
   PubMed Web of Science ®Google Scholar
• Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, . Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38:1101–1110.
   PubMed Web of Science ®Google Scholar
• Wallwork CJ, Parks DA, Schmid-Schonbein GW. Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res. 2003;66:30–37.
   PubMed Web of Science ®Google Scholar
• Laakso JT, Teravainen TL, Martelin E, Vaskonen T, Lapatto R. Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats. J Hypertens. 2004;22:1333–1340.
   PubMed Web of Science ®Google Scholar
• Feig DI, Nakagawa T, Karumanchii SA, Oliver WJ, Kang D-H, Finch J, . Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension. Kidney Int. 2004;66:281–287.
   PubMed Web of Science ®Google Scholar
• Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000;35:746–751.
   PubMed Web of Science ®Google Scholar
• Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, . Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies. Circulation. 2002;105: 2619–2624.
   PubMed Web of Science ®Google Scholar
• Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension. A randomized trial. JAMA. 2008;300:924–932.
   PubMed Web of Science ®Google Scholar
• Farquharson CAJ, Butler R, Hill A, Belch JJF, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106:221–226.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Ozkara A, Selcky Y, Isik B, Turgut F. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007;39:1227–1233.
   PubMed Web of Science ®Google Scholar
• Khan F, George J, Wong K, McSwiggan S, Struthers AD, Belch JJ. Allopurinol treatment reduces arterial wave reflection in stroke survivors. Cardiovasc Therapeutics. 2008;26:247–252.
   PubMed Web of Science ®Google Scholar
• Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2007;49:247–252.
   Web of Science ®Google Scholar
• Kostka-Jeziorny K, Tykarski A. Związek hiperurykemii z innymi czynnikami ryzyka sercowo-naczyniowego u pacjentów z pierwotnym, nieleczonym nadciśnieniem tętniczym w populacji badania RISK. Nadciśnienie Tętnicze. 2008;3:190–199 (in Polish).
   Google Scholar
• SriBhushan Raju D, Ram Mohan P, Naidu MU. Effect of allopurinol on arterial stiffness and endothelial function in patients with chronic renal failure. Ind J Nephrology. 2007; 17:4–8.
   Google Scholar
• Baldus S, Koster R, Chumley P, Heitzer T, Rudolph V, Ostad MA, . Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med. 2005;39:1184–1190.
   PubMed Web of Science ®Google Scholar
• Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, . Effect of hyperuricemia upon endothelial function in patients with increased cardiovascular risk. Am J Cardiol. 2004;94:932–935.
   PubMed Web of Science ®Google Scholar
• Wykretowicz A, Guzik P, Kasinowski R, Krauze T, Bartkowiak G, Dziarmaga M, . Augmentation index, pulse pressure amplification and superoxide anion production in patients with coronary artery disease. Int J Cardiol. 2005;99:289–294.
   PubMed Web of Science ®Google Scholar
• Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy PF, . C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens. 2005;18:1123–1129.
   PubMed Web of Science ®Google Scholar
• Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46; 1118–1122.
   PubMed Web of Science ®Google Scholar
• George J, Carr E, Davies J, Belch JJF, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114:2508–2516.
   PubMed Web of Science ®Google Scholar